FDA NDC Directory · JSON-LD · Markdown

ENFLONSIA

NDC 0006-5073 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameCLESROVIMAB
Labeler / ManufacturerMerck Sharp & Dohme LLC
Marketing categoryBiologic License Application · App BLA761432
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR
Active ingredientsCLESROVIMAB (150 mg/mL)
Marketing started20250609
Package count2

External sources

Source: openFDA. Public-domain (CC0).